Next Article in Journal
Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
Next Article in Special Issue
B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer
Previous Article in Journal
Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas
Previous Article in Special Issue
Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(5), 1100; doi:10.3390/ijms18051100

Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives

1
Unit of Gynecology and Obstetrics, Department of Human Pathology in Adulthood and Childhood “Gaetano Barresi”, University of Messina, 98125 Messina, Italy
2
Department of Obstetrics and Gynecology, Campus Bio Medico University of Rome, 00128 Rome, Italy
3
Unit of Psychodiagnostics and Clinical Psychology, University of Catania, 95124 Catania, Italy
4
Department of General Surgery and Medical Surgical Specialties, University of Catania, 95124 Catania, Italy
5
Department of Human Pathology, Unit of Urology, University of Messina, 98124 Messina, Italy
6
Radiation Oncology Department, AO “Bianchi-Melacrino-Morelli”, 89124 Reggio Calabria, Italy
7
Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 90127 Palermo, Italy
8
Unit of Gynecology and Obstetrics, Desenzano del Garda Hospital, Section of Gavardo, 25085 Gavardo, Brescia, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: William Chi-shing Cho
Received: 12 March 2017 / Revised: 13 May 2017 / Accepted: 16 May 2017 / Published: 20 May 2017
(This article belongs to the Collection Advances in Molecular Oncology)
View Full-Text   |   Download PDF [1025 KB, uploaded 20 May 2017]   |  

Abstract

Carcinosarcomas (CS) in gynecology are very infrequent and represent only 2–5% of uterine cancers. Despite surgical cytoreduction and subsequent chemotherapy being the primary treatment for uterine CS, the overall five-year survival rate is 30 ± 9% and recurrence is extremely common (50–80%). Due to the poor prognosis of CS, new strategies have been developed in the last few decades, targeting known dysfunctional molecular pathways for immunotherapy. In this paper, we aimed to gather the available evidence on the latest therapies for the treatment of CS. We performed a systematic review using the terms “uterine carcinosarcoma”, “uterine Malignant Mixed Müllerian Tumors”, “target therapies”, “angiogenesis therapy”, “cancer stem cell therapy”, “prognostic biomarker”, and “novel antibody-drug”. Based on our results, the differential expression and accessibility of epithelial cell adhesion molecule-1 on metastatic/chemotherapy-resistant CS cells in comparison to normal tissues and Human Epidermal Growth Factor Receptor 2 (HER2) open up new possibilities in the field of target therapy. Nevertheless, future investigations are needed to clarify the impact of these new therapies on survival rate and medium-/long-term outcomes. View Full-Text
Keywords: carcinosarcomas; uterine cancer; genetics; epigenetics; immunotherapy carcinosarcomas; uterine cancer; genetics; epigenetics; immunotherapy
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Vitale, S.G.; Laganà, A.S.; Capriglione, S.; Angioli, R.; La Rosa, V.L.; Lopez, S.; Valenti, G.; Sapia, F.; Sarpietro, G.; Butticè, S.; Tuscano, C.; Fanale, D.; Tropea, A.; Rossetti, D. Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives. Int. J. Mol. Sci. 2017, 18, 1100.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top